REQUEST A DEMO
Total
USD $0.00
Search more companies

Akso Health Group (China)

Main Activities: Credit Intermediation and Related Activities | Business Support Services
Full name: Akso Health Group Profile Updated: August 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

The Company is based on the innovation of health science and technology, creating the source of the comprehensive health industry chain, building medical health products, telemedicine, offline tumor treatment platforms, and vaccine research and development centers.
The Company has adopted an online and offline smart health management model, focusing on the development and implementation of the most valuable smart health management projects. Provide smart health management platform, home care and health management services in many fields such as finance.
The Company building a comprehensive medical and health system, and providing services such as a medical and health product mall (technology and products), a remote diagnosis and treatment platform, an offline tumor treatment platform, and vaccine research and development.
HISTORY
2014 The company was founded
2016The Company is a limited company incorporated under the laws of the Cayman Islands on April 25, 2016.
2017 On November 3, 2017, its ADSs commenced trading on the NASDAQ Global Market under the symbol “HX.”
2018 The Company completed the acquisition Musketeer Group Inc in August 9, 2018.
2019 Since October 2019, the Company has ceased to conduct its P2P business.
2020 On December 30, 2020, the Company completed the disposition transaction of its P2P business. The Company changed its name to Xiaobai Maimai Inc. On August 24, 2020. Its ADSs trade under the symbol “AHG.”
2021 The Company changed its name to “Akso Health Group”
2022 In February 2022, the Company started its business in the US market for the sale of medical devices.
2023 In May 2023, the Company disposed its social E-commerce business and would focus on healthcare business in the future.
2024 On April 30, 2024, the Company amended its authorized share capital, as result, the ordinary shares, par value US 0.0001 each, of the company were re-designated into Class A ordinary shares, par value US 0.0001 each, and Class B ordinary shares, par value US 0.0001 each.)

Headquarters
Room 8201-4-4(A) 2Nd Floor Qiantongyuan Building, No. 44, Moscow Road, Qianwan Bonded Port Area
Beijing; Beijing; Postal Code: 100020

Contact Details: Purchase the Akso Health Group report to view the information.

Website: http://www.hexindai.com

Basic Information
Total Employees:
Purchase the Akso Health Group report to view the information.
Outstanding Shares:
Purchase the Akso Health Group report to view the information.
Financial Auditors:
Purchase the Akso Health Group report to view the information.
Incorporation Date:
2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Beijing Hexin Yongheng Technology Development Co., Ltd
100%
Hexindai Hong Kong Limited (Hong Kong SAR, China)
100%
Hexin E-Commerce Co., Ltd.
Company Performance
Financial values in the chart are available after Akso Health Group report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-81.69%
Total operating revenue
-81.69%
Operating profit (EBIT)
34.95%
Net Profit (Loss) for the Period
-662.58%
Total assets
594.13%
Total equity
1465.88%
Operating Profit Margin (ROS)
-252.99%
Net Profit Margin
-384.77%
Return on Equity (ROE)
7.24%
Quick Ratio
37.85%
Cash Ratio
23.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?